Transaction · 0001231589-26-000022
UTHRUNITED THERAPEUTICS Corp
Mahon Paul A
MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 791.000000 shares for an estimated $430975.16. Reported holdings after the transaction were 48506.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SEVP, GC
- Trade date
- Oct 15, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 49,297 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
UTHR price since this filing
Daily closing prices, with the filing date and available return windowsUTHR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -6.1%1w ago -0.1%1d ago +1.3%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001231589-26-000022 Common Stock
- Transaction date
- Oct 15, 2026 Filed Oct 16, 2026, 08:34 PM · 1d delay
- Shares
- 791 sh $544.85 per share
- Estimated value
- -$430k Computed from shares × price
- Holdings after
- 48,506 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
EVP & GENERAL COUNSEL
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- F2
This transaction was executed in multiple trades at prices ranging from $541.015 to $541.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F3
This transaction was executed in multiple trades at prices ranging from $542.035 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F4
This transaction was executed in multiple trades at prices ranging from $543.155 to $544.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F5
This transaction was executed in multiple trades at prices ranging from $544.22 to $545.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F6
This transaction was executed in multiple trades at prices ranging from $545.23 to $546.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F7
This transaction was executed in multiple trades at prices ranging from $546.27 to $547.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
Related transactions
Same SEC filing0 other transactions
Recent company activity
UTHR0 recent txs